BRIEF-Ambac Financial Group To Acquire Majority Stake In Beat Capital Partners-February 2024-www.financetom.com

BRIEF-Ambac Financial Group To Acquire Majority Stake In Beat Capital Partners

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Ambac Financial Group To Acquire Majority Stake In Beat Capital Partners

Jun 5, 2024 4:39 AM

June 5 (Reuters) - Ambac Financial Group Inc ( AMBC ):

* AMBAC FINANCIAL GROUP, INC. ( AMBC ) TO ACQUIRE MAJORITY STAKE IN

BEAT

CAPITAL PARTNERS

* AMBAC FINANCIAL GROUP INC ( AMBC ): TO ACQUIRE A 60% CONTROLLING

STAKE IN

BEAT CAPITAL PARTNERS LIMITED FOR APPROXIMATELY $282 MILLION

* AMBAC FINANCIAL GROUP INC ( AMBC ): TRANSACTION WILL BE FINANCED

FROM

AVAILABLE CASH AND COMMITTED FINANCING

Source text for Eikon:

Further company coverage:

Previous page： Airbus CEO upbeat on new engine technology, but jury still out Next page： FTC tells Seven & i it intends to probe potential Couche-Tard deal, source says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Airbus CEO upbeat on new engine technology, but jury still out

Sep 10, 2024

WASHINGTON (Reuters) - The head of European planemaker Airbus said novel open-rotor technology being tested by engine maker CFM International offers promising efficiencies and reductions in emissions but that the jury is out on whether it will be viable. Chief Executive Guillaume Faury also told reporters on the sidelines of the Global Aerospace Summit, hosted by the U.S. Chamber of...

FTC tells Seven & i it intends to probe potential Couche-Tard deal, source says

Sep 10, 2024

NEW YORK (Reuters) - The U.S. Federal Trade Commission has notified Seven & i of its intention to investigate a potential takeover of the convenience store chain by Canada's Alimentation Couche-Tard over antitrust concerns, a source familiar with the matter said. Couche-Tard proposed to buy Seven & i for $38.5 billion, an offer that the Japense retail giant rejected, in...

Roivant Sciences' Lung Disease Drug Candidate Shows Potential in Early Testing, Advances to Phase 2 Trial

Sep 10, 2024

11:33 AM EDT, 09/10/2024 (MT Newswires) -- Roivant Sciences ( ROIV ) said Tuesday its Pulmovant unit presented positive data from phase 1b testing of its mosliciguat drug candidate, with the prospective treatment for pulmonary hypertension showing the potential for differentiated efficacy, safety and convenience in patients during a recent proof-of-concept trial. Mosliciguat also demonstrated a favorable safety profile and...

Rubrik shares fall as Microsoft-backed firm nears IPO lockup expiry

Sep 10, 2024

(Reuters) - Shares of Rubrik ( RBRK ) fell more than 6% on Tuesday, as the markets braced for the expiry of a lockup period tied to its initial public offering, clouding the Microsoft ( MSFT )-backed cybersecurity company's upbeat second-quarter revenue. The lockup period expires on Wednesday and typically that would allow company insiders and pre-IPO investors to sell...